Weather: Xiamen Overcast 15-18℃ Wind Scale 4 Precipitation Probability 0%
  中文网站  |  English

Home > Research > Achievements

60 panents

Date:2016/9/2 Views:1390

32 Patents

 

No.

Content

Country

Patent Number/Patent Application Number

1

Paired proteins which has fluorescence resonance energy transfer and its function

China

ZL 00 1 30292.2

2

Novel green fluorescent protein

China

ZL 01 1 09876.7

3

Green fluorescent protein and its coding sequence

China

ZL 00 1 33802.1

4

Hepatitis E virus monoclonal antibodies and its application

China

ZL 02 8 22218.0

5

Hepatitis E virus monoclonal antibodies or its bioactivity fragment and its application

Australia

2002349727

6

A monoclonal antibodies of hipotype H5 avian influenza virus hemagglutinin albumen and its preparation method and application

China

ZL 2005 1 0007308.X

7

Protein Combinations which has fluorescence resonance energy transfer and its application

China

ZL 2004 1 0062737.2

8

A method which aim at Substance of Allosteric phenomenon of target space and/or active described in the target biological activity

China

ZL 02 1 04482.1

9

The prevention, diagnose and therapy of hepatitis E virus poly-peptide and the Diagnostic reagents and vaccines which apply them

Korea

10-0927221

10

The prevention, diagnose and therapy of hepatitis E virus poly-peptide and the Diagnostic reagents and vaccines which apply them

America

7615228

11

The prevention, diagnose and therapy of hepatitis E virus poly-peptide and the Diagnostic reagents and vaccines which apply them

Mexico

272941

12

The prevention, diagnose and therapy of hepatitis E virus poly-peptide and the Diagnostic reagents and vaccines which apply them

India

235951

13

The method and diagnostic kit which Joint Detection HBV Pre S1 antigen and core antigen

China

ZL 2006 1 0090512.7

14

The method and diagnostic kit which Joint Detection HBV Pre S1 antigen and core antigen

Hong Kong, China

HK1099361/07105485.4

15

Hepatitis E virus monoclonal antibodies or bioactivity fragment and its application

America

7786264

16

Hepatitis E virus monoclonal antibodies or bioactivity fragment and its application

India

241063

17

Hepatitis E virus monoclonal antibodies or bioactivity fragment and its application

Indonesia

P0025956

18

recombinant plasmid 、the modification of hematopoietic stem cells which can be applied in AIDS treatment and its method

China

ZL 2005 1 0112917.1

19

Hepatitis E virus monoclonal antibodies or bioactivity fragment and its application

Korea

10-1020256

20

Hepatitis E virus monoclonal antibodies or bioactivity fragment and its application

Mexico

285180

21

Truncated human papilloma virus L1 Protein Type 6

China

ZL 2008 1 0111390.4

22

Truncated human papilloma virus L1 Protein Type 18

China

ZL 2008 1 0093817.2

23

A Nucleic acid amplification and detection reaction tube

China

ZL 2011 2 0449250.5

24

A method and composition which to immune or preparation monoclonal antibodies

China

ZL 2006 1 0081554.4

25

RNA interference target which can be apply in AIDS treatment

China

ZL 2008 1 0110007.3

26

RNA interference target which can be apply in AIDS treatment

China

ZL 2011 1 0243212.9

27

Truncated human papilloma virus L1 Protein Type 6

Hong Kong, China

HK1124343/09102006.9

28

Truncated human papilloma virus L1 Protein Type 16

China

ZL 2008 1 0093816.8

29

Specific binding monoclonal antibodies of hipotype H5 avian influenza virus hemagglutinin albumen or bioactivity fragment and its application

China

ZL 2008 1 0110869.6

30

RNA interference target which can be apply in HBV treatment

China

ZL 2008 1 0110686.4

31

Avian influenza virus H5 neutralization epitope simulation peptide and its application

China

ZL 2008 1 0133705.5

32

Supervisory control and management of equipment

China

ZL 2013 2 0322359.1

67 Patent Application

 

No.

Content

Application Number

1

A monoclonal antibodies of hipotype H5 avian influenza virus hemagglutinin albumen and its preparation method and application

200510007308.X

2

monoclonal antibodies of hipotype H5 avian influenza virus hemagglutinin albumen or bioactivity fragment and its application

200610002312.1

3

A method and composition which to immune or preparation monoclonal antibodies

200610081554.4

4

200610090512.7

5

Late L1 protein purification of human papilloma virus from prokaryote

200610140613.0

6

Truncated human papilloma virus L1 Protein Type 16

200710097762.8

7

Truncated human papilloma virus L1 Protein Type 18

200710097763.2

8

Truncated human papilloma virus L1 Protein Type 6

200710105764.7

9

Truncated human papilloma virus L1 Protein Type 11

200710105763.2

10

A method of detecting Human papilloma virus neutralizing antibody

200810004346.3

11

The prevention, diagnose and therapy of hepatitis e virus poly-peptide and the Diagnostic reagents and vaccines which apply them

200810085110.7

12

Truncated human papilloma virus L1 Protein Type 16

200810093816.8

13

Truncated human papilloma virus L1 Protein Type 18

200810093817.2

14

RNA interference target which can be apply in AIDS treatment

200810110007.3

15

A monoclonal antibodies of hipotype H5 avian influenza virus hemagglutinin albumen or its bioactivity fragment and its application

200810110869.6

16

RNA interference target which can be apply in HBV treatment

200810110686.4

17

Avian influenza virus H5 neutralization epitope simulation peptide and its application

200810133705.5

18

The humanized antibody or bioactivity fragment of H5 hipotype avian influenza virus hemagglutinin albumen and its application

200810167047.1

19

Avian influenza virus H5 conservative neutralization epitope simulation peptide and its application

200810182618.9

20

 Hepatitis B virus monoclonal antibodies variable region sequence and genetic engineering antibody which contain these variable region Hepatitis b virus monoclonal antibodies and its application

200810178602.0

21

A method of detecting Human papilloma virus neutralizing antibody

200910001113.2

22

A method and kit which can detect virus-neutralizing antibodies quickly

200910143481.0

23

ORF7 defective  varicella wild and the vaccine which contain it and its application

200910157387.0

24

The humanized antibody or bioactivity fragment of hipotype H5 avian influenza virus hemagglutinin albumen and its application

200910179075.X

25

Avian influenza virus H5 conservative neutralization epitope simulation peptide and its application

200910225192.5

26

Truncated human papilloma virus L1 Protein Type 52

201010216189.X

27

Truncated human papilloma virus L1 Protein Type 58

201010232875.6

28

Neutralization epitope peptide of enterovirus type 71 and its application

201010541859.5

29

Neutralization epitope peptide of enterovirus type 71 and its application

201110357994.9

30

RNA Interference targets which can be used to induce hepatocytes injured

201110006691.2

31

Anti CD4 protein monoclonal antibodies and its bioactivity fragment and application

201110045952.1

32

Epitope of Influenza a virus capsid protein and its application

201110122466.5

33

Truncated human papilloma virus L1 Protein Type 33

201110136560.6

34

fusion protein which include diphtheria toxin nontoxic mutant CRM197

201110145419.2

35

A polypeptide which can induce granulation and its application

201110154637.2

36

Truncated human papilloma virus L1 Protein Type 52

201110182799.7

37

Truncated human papilloma virus L1 Protein Type 58

201110198625.X

38

Virus-like particles ‘Assembly Mechanism of Hepatitis E virus and its preparation method

201110234805.9

39

RNA interference target which can be apply in AIDS treatment

201110243212.9

40

A reaction tubes to augment and detect nucleic acid

201110360350.5

41

A reaction tubes to augment and detect nucleic acid

201120449250.5

42

A chimeric recombinant antigen and its application

201110370731.1

43

A method and device to perform PCR in constant heat reservoir

201110456811.9

44

RNA Interference targets which can be used to induce hepatocytes injured

201210010355.X

45

Anti-HBc quantitative detection method and its application in monitoring and control of chronic hepatitis b patients with disease progression and predict treatment efficacy

201210019389.5

46

201210047125.0

47

Anti-CD4 protein monoclonal antibodies and its bioactivity fragment and application

201210047960.4

48

fusion protein which include diphtheria toxin nontoxic mutant CRM197 or its fragment

201210181392.7

49

Antibody of specific binding highly pathogenic avian influenza virus

201210190369.4

50

Peptides and antibodies which are used in the treatment of chronic HBV and other related disease

201210190329.X

51

Anti-HPVL2 protein broad spectrum neutralizing monoclonal antibodies or its fraction-antibody binding and its application

201210190279.5

52

Anti-HPVL2 protein broad spectrum monoclonal antibodies or its fraction-antibody binding and its application

201210190399.5

53

VP2 antigen neutralization epitope peptide of enterovirus type 71 and its application

201210241306.7

54

A method to prepare rotavirus double virus particles in vitro

201210350365.8

55

Antibody of specific binding hepatitis E virus type 3 and type 4 and its application

201310069913.4

56

Epitope of RSV fusion protein and the antibody which can locate it

201310082338.1

57

Broad spectrum monoclonal antibodies which can locate hipotype H1 and H5 avian influenza virus hemagglutinin albumen and the epitope which it can locate

201310113101.5

58

monoclonal antibodies of hipotype H5 avian influenza virus hemagglutinin albumen or its bioactivity fragment and its application

201310131000.0

59

RNA interference target which can be apply in HBV treatment

201310131754.6

60

An optimized gene sequence of human papilloma virus L1 Protein Type 31

201310217596.6

61

Capsid protein interaction site of human papilloma virus L1L2 and its application

201310220120.8

62

Truncated human papilloma virus L1 Protein Type 45

201310217863.X

63

Method to prepare protein of Hepatitis e virus particles

201310218823.7

64

supervisory control and management of equipment

201320322359.1

65

Peptides and antibodies which are used in the treatment of chronic HBV and other related disease

201310222728.4

66

VP2 antigen neutralization epitope peptide of enterovirus type 71 and its application

201310291205.5

67

Fluorescence scanning detector

201310396508.3

Website No. D200327 © Xiamen University